Jupiter Asset Management LTD Merck & Co., Inc. Transaction History

Jupiter Asset Management LTD

$9.74 Billion
Q1 2025

A detailed history of Jupiter Asset Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 932,832 shares of MRK stock, worth $71.7 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

932,832

Holding current value

$71.7 Million

% of portfolio

0.86%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$83.01 - $101.02 $77.4 Million - $94.2 Million	932,832 New	932,832 $83.7 Million
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $28.8 Million - $33.4 Million	258,700 Added 8540.77%	261,729 $29.7 Million
Q2 2024 Aug 08, 2024	BUY	$123.8 - $132.96 $374,990 - $402,735	3,029 New	3,029 $374,000
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $72.8 Million - $79.2 Million	-726,538 Reduced 99.69%	2,264 $246,000
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $74.7 Million - $83 Million	725,854 Added 24621.91%	728,802 $75 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $471,693 - $514,124	-4,343 Reduced 59.57%	2,948 $340,000
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $37 Million - $41.3 Million	-359,818 Reduced 98.01%	7,291 $775,000
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $36.6 Million - $46.9 Million	-418,688 Reduced 53.28%	367,109 $40.7 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $7.01 Million - $7.87 Million	82,929 Added 11.8%	785,797 $67.7 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $11 Million - $12.4 Million	-131,452 Reduced 15.76%	702,868 $64.2 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $8.24 Million - $9.23 Million	-112,047 Reduced 11.84%	834,320 $68.5 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $65.8 Million - $82.4 Million	910,200 Added 2516.66%	946,367 $73 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $20,500 - $22,545	-286 Reduced 0.78%	36,167 $2.72 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $36.8 Million - $40.7 Million	-522,891 Reduced 93.48%	36,453 $2.84 Million
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $7.11 Million - $8.38 Million	103,269 Added 22.64%	559,344 $43.1 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $19.6 Million - $21.7 Million	272,944 Added 149.04%	456,075 $37.3 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $3.97 Million - $4.5 Million	54,241 Added 42.08%	183,131 $15.2 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $1.92 Million - $2.18 Million	-27,229 Reduced 17.44%	128,890 $9.96 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $342,714 - $475,018	-5,409 Reduced 3.35%	156,119 $12 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $2.03 Million - $2.3 Million	26,230 Added 19.39%	161,528 $14.7 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $1.96 Million - $2.14 Million	25,758 Added 23.51%	135,298 $11.4 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $91,141 - $106,474	-1,305 Reduced 1.18%	109,540 $9.19 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $1.06 Million - $1.21 Million	15,259 Added 15.96%	110,845 $9.22 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $483,167 - $560,708	-7,406 Reduced 7.19%	95,586 $7.31 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $97,265 - $114,378	1,686 Added 1.66%	102,992 $7.31 Million
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $485,274 - $570,146	-9,547 Reduced 8.61%	101,306 $6.15 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $1.56 Million - $1.81 Million	-30,602 Reduced 21.63%	110,853 $6.04 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $8.3 Million - $8.93 Million	141,455	141,455 $9.06 Million

Others Institutions Holding MRK

# of Institutions

3,894

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $195B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Account

Jupiter Asset Management LTD Merck & Co., Inc. Transaction History